Lantern Pharma Inc. Deferred Tax Liabilities, Unrealized Gains on Trading Securities
Lantern Pharma Inc. (LTRN) had Deferred Tax Liabilities, Unrealized Gains on Trading Securities of $438 as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities · last filed 2026-03-30
- 2025-12-31: Deferred Tax Liabilities, Unrealized Gains on Trading Securities $438.00.
- 2024-12-31: Deferred Tax Liabilities, Unrealized Gains on Trading Securities $1.84K.
| Period end | Deferred Tax Liabilities, Unrealized Gains on Trading Securities |
|---|---|
| 2025-12-31 | $438.00 10-K · filed 2026-03-30 |
| 2024-12-31 | $1.84K 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |